REGN•benzinga•
Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Lowers Price Target to $940
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 30, 2025 by benzinga